logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hisamitsu Miyaaki

Nagasaki University Graduate School of Biomedical Sciences
H指数:26
被引数:2,763

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

durvalumab联合tremelimumab治疗肝细胞癌患者淋巴细胞计数早期变化可预测临床结局

Journal of Gastroenterology and Hepatology
IF3.4
2026-10-070
OAAI
Yuichi Honma; Shigeo Shimose; Takanori Ito; Issei Saeki; Joji Tani; Takanori Matsuura; Tetsu Tomonari; Yasuto Takeuchi; Nobuhito Taniki; Kyo Sasaki; Ryu Sasaki; Takeshi Hatanaka; Satoru Kakizaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Tomotake Shirono; Satoshi Itano; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Yuki Kanayama; Hisamitsu Miyaaki; Sohji Nishina; Nobuhiro Nakamoto; Motoyuki Otsuka; Tetsuji Takayama; Yuzo Kodama; Hideki Kobara; Taro Takami; Hiroki Kawashima; Takumi Kawaguchi; Masaru Harada
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗在Child-Pugh B级肝细胞癌患者中的有效性与安全性

LIVER INTERNATIONAL
IF5.2
2025-11-280
OAAI
Sasaki, Ryu; Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Miuma, Satoshi; Shirono, Tomotake; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Miyaaki, Hisamitsu
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗后序贯免疫检查点抑制剂再治疗的结局

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
2025-11-010
OAAI
Ito, Takanori; Shimose, Shigeo; Saeki, Issei; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Miyaaki, Hisamitsu; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Takami, Taro; Kawaguchi, Takumi; Kawashima, Hiroki
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination

血清生长分化因子15可作为预测丙型肝炎病毒肝硬化患者病毒清除后预后的新型生物标志物

Hepatology Research
IF3.4
2025-09-180
OAAI
Yuta Myojin; Hayato Hikita; Yuki Tahata; Kenji Fukumoto; Seiya Kato; Yoichi Sasaki; Shusuke Kumazaki; Atsunori Tsuchiya; Masaru Enomoto; Daiki Miki; Hiroshi Yatsuhashi; Hidekatsu Kuroda; Yoshihito Uchida; Hitoshi Yoshiji; Taro Yamashita; Seiichi Mawatari; Nobuharu Tamaki; Hisamitsu Miyaaki; Yasuhiro Asahina; Goki Suda; Kentaro Matsuura; Yasunari Nakamoto; Yoichi Hiasa; Taro Takami; Kumiko Shirai; Kazuki Maesaka; Kazuhiro Murai; Yuki Makino; Yoshinobu Saito; Takahiro Kodama; Tomohide Tatsumi; Tetsuo Takehara
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study

代谢相关脂肪性肝病与度伐利尤单抗和特瑞普利单抗在晚期肝细胞癌患者临床结局中的关联：一项多中心研究

Hepatology Research
IF3.4
2025-08-210
PRE
Takeshi Hatanaka; Shigeo Shimose; Takanori Ito; Joji Tani; Tetsu Tomonari; Issei Saeki; Yasuto Takeuchi; Kyo Sasaki; Yuichi Honma; Ryu Sasaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Satoshi Itano; Yuki Kanayama; Tomotake Shirono; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Sohji Nishina; Motoyuki Otsuka; Hideki Kobara; Taro Takami; Tetsuji Takayama; Takumi Kawaguchi; Hiroki Kawashima; Masaru Harada; Hisamitsu Miyaaki; Satoru Kakizaki; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group
Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid

化疗诱导的中性粒细胞减少预测接受纳米脂质体伊立替康、氟尿嘧啶和甲酰四氢叶酸治疗的胰腺癌患者的短期结局

International Journal of Cancer
IF4.7
2025-08-010
PRE
Tomonori Araki; Tsuyoshi Shirakawa; Mototsugu Shimokawa; Taiga Otsuka; Kohei Hayashi; Yuki Sonoda; Takuya Honda; Hisamitsu Miyaaki; Junichi Nakazawa; Hozumi Shimokawa; Yudai Shinohara; Futa Koga; Noriko Oza; Hisanobu Oda; Shigeyuki Takeshita; Shiho Arima; Shuji Arita; Yasunori Kawaguchi; Kazuo Nishikawa; Satoshi Otsu; Hiroki Taguchi; Kenichi Jikuya; Tatsunori Sakai; Yujiro Ueda; Takahiro Sakae; Norimasa Araki; Hironori Sawase; Yasushi Ide; Machiko Kawahira; Kenta Nio; Toshihiko Mizuta; Kenji Mitsugi
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy

治疗后血清CXCL10水平可对慢性丙型肝炎病毒感染导致的代偿期和失代偿期肝硬化患者的生存情况进行分层，尤其是在直接抗病毒治疗后。

Journal of Gastroenterology
IF5.5
2025-07-010
PRE
Takanori Suzuki; Kentaro Matsuura; Yuki Tahata; Hayato Hikita; Ryotaro Sakamori; Norifumi Kawada; Nobuyuki Enomoto; Daiki Miki; Hiroshi Yatsuhashi; Hidekatsu Kuroda; Taro Yamashita; Hitoshi Yoshiji; Masayuki Kurosaki; Seiichi Mawatari; Hisamitsu Miyaaki; Yasuhiro Asahina; Yoichi Hiasa; Satoshi Mochida; Yasunari Nakamoto; Taro Takami; Takahiro Kodama; Tomohide Tatsumi; Tetsuo Takehara
Intratumoral Fibrotic Features are Associated with Lymph Node Metastasis and Recurrence in Patients with Advanced Colon Cancer

肿瘤内纤维化特征与进展期结肠癌患者的淋巴结转移和复发相关

Modern Pathology
IF5.5
2025-06-240
PRE
Ayako Mine; Maiko Tabuchi; Yasuhiko Nakao; Nazigul Zhumagazhiyeva; Takahiro Motoyama; Keiichi Hashiguchi; Eri Yoshioka; Kanan Matsushima; Junya Shiota; Taro Akashi; Moto Kitayama; Hiroko Inomata; Kayoko Matsushima; Naoyuki Yamaguchi; Takashi Nonaka; Kazuhiko Nakao; Hisamitsu Miyaaki; Yuko Akazawa
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosis

治疗前血清血管生成素-2可预测接受索磷布韦和韦帕他韦成功清除HCV后，HCV相关失代偿期肝硬化患者的预后及肝脏功能储备

Journal of Gastroenterology
IF5.5
2025-06-200
PRE
Naoki Kawagishi; Goki Suda; Yuki Tahata; Hayato Hikita; Takahiro Kodama; Satoshi Mochida; Nobuyuki Enomoto; Seiichi Mawatari; Hidekatsu Kuroda; Daiki Miki; Masayuki Kurosaki; Yoichi Hiasa; Norifumi Kawada; Taro Yamashita; Hiroshi Yatsuhashi; Hitoshi Yoshiji; Naoya Kato; Taro Takami; Hisamitsu Miyaaki; Kentaro Matsuura; Yasuhiro Asahina; Yoshito Itoh; Ryosuke Tateishi; Yasunari Nakamoto; Eiji Kakazu; Shuji Terai; Masahito Shimizu; Yoshiyuki Ueno; Norio Akuta; Masatsugu Ohara; Naoya Sakamoto; Tetsuo Takehara
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria

仑伐替尼联合经导管动脉化疗栓塞与阿替利珠单抗联合贝伐珠单抗作为超出“七限”标准的中间期肝细胞癌的一线治疗比较分析

Journal of Gastroenterology and Hepatology
IF3.4
2025-05-310
PRE
Takashi Niizeki; Seiichi Mawatari; Michihiko Shibata; Ryu Sasaki; Shinji Itoh; Satoshi Shakado; Rie Sugimoto; Yusuke Morita; Takuya Kuwashiro; Mizuki Endo; Masao Iwao; Yasuhide Motoyoshi; Masahito Nakano; Shigeo Shimose; Hirokazu Takahashi; Hiroshi Yatsuhashi; Fumihito Hirai; Tomoharu Yoshizumi; Hisamitsu Miyaaki; Takumi Kawaguchi; Akio Ido; Masaru Harada
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer

曲妥珠单抗deruxtecan治疗HER2-positive胃癌或胃食管交界处癌的疗效和安全性的预后和预测因素

GASTRIC CANCER
IF5.1
2024-11-020
OAAI
Jubashi, Amane; Nakayama, Izuma; Koganemaru, Shigehiro; Sakamoto, Naoya; Oda, Shioto; Matsubara, Yuki; Miyashita, Yu; Sato, Seiya; Ushiyama, Shinpei; Kobayashi, Akinori; Okazaki, Ukyo; Okemoto, Dai; Yamamoto, Kazumasa; Mishima, Saori; Kotani, Daisuke; Kawazoe, Akihito; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Yoshino, Takayuki; Miyaaki, Hisamitsu; Nakao, Kazuhiko; Shitara, Kohei
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy
HEPATOLOGY RESEARCH
IF3.4
2024-10-290
OAAI
Tahata, Yuki; Hikita, Hayato; Mochida, Satoshi; Enomoto, Nobuyuki; Kawada, Norifumi; Ido, Akio; Miki, Daiki; Kurosaki, Masayuki; Yoshiji, Hitoshi; Sakamori, Ryotaro; Kuroda, Hidekatsu; Yatsuhashi, Hiroshi; Yamashita, Taro; Hiasa, Yoichi; Kato, Naoya; Miyaaki, Hisamitsu; Ueno, Yoshiyuki; Itoh, Yoshito; Matsuura, Kentaro; Takami, Taro; Asahina, Yasuhiro; Suda, Goki; Akuta, Norio; Tateishi, Ryosuke; Nakamoto, Yasunari; Kakazu, Eiji; Terai, Shuji; Shimizu, Masahito; Miyazaki, Masanori; Nozaki, Yasutoshi; Sobue, Satoshi; Yano, Hiroki; Miyaki, Tomokatsu; Moriuchi, Akihiro; Hori, Takeshi; Shirai, Kumiko; Murai, Kazuhiro; Saito, Yoshinobu; Kodama, Takahiro; Tatsumi, Tomohide; Yamada, Tomomi; Takehara, Tetsuo

研究方向

暂未获取到该数据
K
Kazuhiko Nakao
H 指数:57论文数:565被引数:1.4万
S
Satoshi Miuma
H 指数:21论文数:137被引数:1,657
T
Tatsuki Ichikawa
H 指数:34论文数:205被引数:4,682
O
Ozawa, Eisuke
H 指数:0论文数:1被引数:21
N
Naota Taura
H 指数:24论文数:158被引数:2,049
R
Ryu Sasaki
H 指数:14论文数:90被引数:924
H
Hidetaka Shibata
H 指数:21论文数:96被引数:1,648
M
Masanori Fukushima
H 指数:57论文数:522被引数:1.2万
S
Susumu Eguchi
H 指数:45论文数:906被引数:1.2万
M
Masafumi Haraguchi
H 指数:12论文数:66被引数:376